FILE PHOTO: A specialist works during the production of Gam-COVID-Vac, also known as Sputnik-V, vaccine against the coronavirus disease (COVID-19) at a facility of BIOCAD biotechnology company in Saint Petersburg, Russia December 4, 2020. Picture taken December 4, 2020. REUTERS/Anton Vaganov
MOSCOW (Reuters) -Russian developers published fresh trial results for their Sputnik V coronavirus vaccine on Monday based on new data, and said the shot had again been found to be 91.4% effective in providing protection from COVID-19.
More than 200,000 people have already been vaccinated against the disease as part of Russia's mass inoculation programme, which began in September alongside a Moscow-based human trial of the shot.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
